Skip to main navigation Skip to search Skip to main content

Preclinical drug development must consider the impact on metastasis

  • Patricia S. Steeg
  • , Robin L. Anderson
  • , Menashe Bar-Eli
  • , Ann F. Chambers
  • , Suzanne A. Eccles
  • , Kent Hunter
  • , Kazuyuki Itoh
  • , Yibin Kang
  • , Lynn M. Matrisian
  • , Jonathan P. Sleeman
  • , Dan Theodorescu
  • , Erik W. Thompson
  • , Danny R. Welch

Research output: Contribution to journalShort surveypeer-review

Original languageEnglish (US)
Pages (from-to)4529-4530
Number of pages2
JournalClinical Cancer Research
Volume15
Issue number14
DOIs
StatePublished - Jul 15 2009

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Fingerprint

Dive into the research topics of 'Preclinical drug development must consider the impact on metastasis'. Together they form a unique fingerprint.

Cite this